RN7SL561P

Across TCGA pan-cancer cohorts, RN7SL561P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RN7SL561P data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher RN7SL561P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL561P expression acts as an unfavorable survival marker, although some lineages such as STAD and SKCM show a favorable association.

TGCT, STAD, and BLCA are the cancer types where RN7SL561P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	OS	Tertile	II,III,IV	0.501	0.996	<.001	90	view →
STAD	OS	Tertile	All	0.753	0.447	.006	37	view →
BLCA	OS	Tertile	IV	0.074	0.599	<.001	36	view →
READ	DFS	Tertile	All	0.336	0.843	.023	36	view →
GBM	OS	Tertile	All	0.028	0.420	<.001	30	view →
KIRC	OS	Tertile	All	0.507	0.664	.004	28	view →
HNSC	OS	Tertile	IV	0.029	0.643	<.001	27	view →
DLBC	DFS	Tertile	III,IV	0.070	0.855	.008	21	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	18	view →
SKCM	DFS	Tertile	III,IV	0.612	0.207	.012	18	view →
LGG	DFS	Tertile	All	0.555	0.825	.049	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RN7SL561P–TGCT (OS)

Open the TGCT breakdown →